Cargando…
Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries
Autores principales: | Adhikari, Sugat, Khadka, Sitaram, Dahal, Sadhana, Shrestha, Dhan Bahadur, Shahi, Janak, Bajgain, Yogesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592638/ https://www.ncbi.nlm.nih.gov/pubmed/33139967 http://dx.doi.org/10.1007/s40267-020-00791-1 |
Ejemplares similares
-
Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis()
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2021) -
Preventing COVID-19 in low- and middle-income countries
por: Khadka, Sitaram, et al.
Publicado: (2020) -
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis
por: Budhathoki, Pravash, et al.
Publicado: (2020) -
Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020) -
Pharmacometrics: A New Era of Pharmacotherapy and Drug Development in Low- and Middle-Income Countries
por: Usman, Muhammad, et al.
Publicado: (2023)